Summary

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.

● The group's high margin levels account for strong profits.

● The group usually releases upbeat results with huge surprise rates.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.


Weaknesses

● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 81.62 times its estimated earnings per share for the ongoing year.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.